Everett Vokes to Proto-Oncogene Proteins c-mdm2
This is a "connection" page, showing publications Everett Vokes has written about Proto-Oncogene Proteins c-mdm2.
Connection Strength
0.232
-
MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trial. Nat Commun. 2026 Mar 19; 17(1).
Score: 0.232
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.